Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Jul 2025 for HARVARD BIOSCIENCE INC. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Katherine A. Eade: trading record in brief
Katherine A. Eade is a declared insider of Harvard Bioscience Inc (board member), with filings sourced from SEC (Form 4). Between 25 May 2021 and 16 July 2025, the trades on record add up to 7 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 18 July 2025 came the latest disclosure, a share grant in Harvard Bioscience Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Katherine A. Eade
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
110,000 shares0Common StockSEC:0001104659-25-069051:0
45,872 shares0Common StockSEC:0000921895-24-001305:0
25,554 shares0Common StockSEC:0000921895-23-001329:0
38,259 shares0Common StockSEC:0000921895-22-001801:0
2,525 shares0Common StockSEC:0000921895-22-000031:0
1,401 shares0Common StockSEC:0000921895-21-002899:0
14,400 shares0Common StockSEC:0000921895-21-001510:0
7 of 7 declarations
